Belite Bio, Inc. ADR (BLTE)
US Market

Belite Bio, Inc. ADR (BLTE) Stock Price & Analysis


BLTE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$14.22 - $44.70
Previous Close$16.49
Average Volume (3M)20.83K
Market Cap
Enterprise Value$555.02M
Total Cash (Recent Filing)$42.09M
Total Debt (Recent Filing)$866.00K
Price to Earnings (P/E)N/A
Aug 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding24,898,908
10 Day Avg. Volume15,780
30 Day Avg. Volume20,833
Standard Deviation0.33
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/EbitdaN/A
Price Target Upside248.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Belite Bio, Inc. ADR’s price range in the past 12 months?
Belite Bio, Inc. ADR lowest stock price was $14.22 and its highest was $44.70 in the past 12 months.
    What is Belite Bio, Inc. ADR’s market cap?
    Currently, no data Available
    When is Belite Bio, Inc. ADR’s upcoming earnings report date?
    Belite Bio, Inc. ADR’s upcoming earnings report date is Aug 09, 2023 which is in 69 days.
      How were Belite Bio, Inc. ADR’s earnings last quarter?
      Currently, no data Available
      Is Belite Bio, Inc. ADR overvalued?
      According to Wall Street analysts Belite Bio, Inc. ADR’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Belite Bio, Inc. ADR pay dividends?
        Belite Bio, Inc. ADR does not currently pay dividends.
        What is Belite Bio, Inc. ADR’s EPS estimate?
        Belite Bio, Inc. ADR’s EPS estimate is -$0.18.
          How many shares outstanding does Belite Bio, Inc. ADR have?
          Belite Bio, Inc. ADR has 24,898,909 shares outstanding.
            What happened to Belite Bio, Inc. ADR’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Belite Bio, Inc. ADR?
            Currently, no hedge funds are holding shares in BLTE


            Belite Bio, Inc. ADR Stock Smart Score

            The Belite Bio, Inc. ADR stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Belite Bio, Inc. ADR

            Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.


            Top 5 ETFs holding BLTE

            Currently, no data available
            Please return soon. This page is being updated.
            Up to five ETFs with an Outperform Smart Score that hold BLTE. The ETFs are listed according to market value of BLTE within the ETF


            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Price & Change
            Pliant Therapeutics
            Amneal Pharmaceuticals
            Third Harmonic Bio, Inc.

            Popular Stocks

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis